AI (Artificial Intelligence) in Genomics Market Research Report 2023
March 31, 2023 05:38 ET
|
Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "AI in Genomics Market 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global AI in genomics market is expected to grow...
Global Gene Editing Partnering Analysis Report 2023: Terms and Agreements for 400+ Deals Signed Since 2010 by the World's Leading Healthcare Companies
March 09, 2023 05:19 ET
|
Research and Markets
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "Global Gene Editing Partnering Terms and Agreements 2010 to 2023" report has been added to ResearchAndMarkets.com's offering.The Global Gene Editing...
India Gene Editing Technology Market Databook Report 2023-2027: CRISPR, Meganucleases, TALEN, and ZFN Products, Delivery Method, Disease/Disorders, and Applications
March 03, 2023 06:58 ET
|
Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "India Gene Editing Technology Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's...
Intellia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NTLA-2002, an In Vivo CRISPR-Based Investigational Therapy for the Treatment of Hereditary Angioedema (HAE)
March 02, 2023 07:00 ET
|
Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies...
Global Pharmacogenomics Market Report 2022: A $10.5 Billion Market by 2030 - Key Players are Extensively Involved in Seeking Approvals and Product Launches to Remain Competitive
February 28, 2023 07:53 ET
|
Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market Growth Analysis by Service, Technology, Application, End-user - Industry Revenue Estimation and Demand Forecast to 2030"...
China Gene Editing Technology Market Databook Report 2023: Business and Investment Opportunities to 2027
February 27, 2023 10:33 ET
|
Research and Markets
Dublin, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The "China Gene Editing Technology Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's...
Global Gene Editing Technology Market Report 2023 Featuring bluebird, Beam, Caribou Bio, Cellectis, Allogene, Intellia TX, Editas Medicine, Verve, AstraZeneca, Merck, & Thermo Fisher Scientific
February 21, 2023 11:43 ET
|
Research and Markets
Dublin, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The "Global Gene Editing Technology Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial...
Gene Therapy Global Market Report 2023: Increasing Prevalence of Cancer Fuels Demand
February 16, 2023 08:53 ET
|
Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type...
Advances in Gene Editing Technologies in Healthcare, 2023 Research Report - Next-Generation Genome Editing Tools and Improved Delivery Are Bolstering Gene Editing Therapeutics and Diagnostics
February 10, 2023 10:53 ET
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Advances in Gene Editing Technologies in Healthcare" report has been added to ResearchAndMarkets.com's offering. CRISPR, ZFNs, and TALENs are...
CRISPR Technology Global Markets Report 2023: A $9.2 Billion Market by 2027, from $3.3 Billion in 2022
January 25, 2023 04:08 ET
|
Research and Markets
Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "CRISPR Technology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides detailed exposure to the...